Allogene Therapeutics (ALLO) Revenue

Compare

1,683 Followers

Statistics Market Cap Revenue

Allogene Therapeutics Revenue

Allogene Therapeutics had a revenue of 0.00 in the quarter ending Dec 31, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2025, Allogene Therapeutics had annual revenue of 0.00 with -100.00% growth.

Revenue (ttm)

0.00

Revenue Growth

-100.00%

P/S Ratio

―

Revenue/Employee

Employees

226

Market Cap

$550.94M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	―	-22.00K	-100.00%
Dec 31, 2024	22.00K	-73.00K	-76.84%
Dec 31, 2023	95.00K	-61.00K	-39.10%
Dec 31, 2022	156.00K	-113.93M	-99.86%
Dec 31, 2021	114.09M	―	+∞%
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―